NSRX
Nasus Pharma Ltd
3월 13일 3:55 PM ET (한국 3/14 04:55)
$5.00
+0.38 ▲ +8.23%
🌙 3월 13일 7:59 PM ET (한국 3/14 08:59)
$5.26
+0.26 ▲ +5.20%
| Index | - | P/E | - | EPS (ttm) | - | Insider Own | 66.02% | Shs Outstand | 0.01B | Perf Week | 2.88% |
| Market Cap | 0.04B | Forward P/E | - | EPS next Y | -13.65% | Insider Trans | - | Shs Float | 0.00B | Perf Month | -10.71% |
| Enterprise Value | 0.04B | PEG | - | EPS next Q | - | Inst Own | 0.03% | Short Float | 0.3% | Perf Quarter | -23.08% |
| Income | - | P/S | - | EPS this Y | -65.79% | Inst Trans | -0.06% | Short Ratio | 1.39 | Perf Half Y | -38.57% |
| Sales | - | P/B | - | EPS next 5Y | -12.43% | ROA | - | Short Interest | 0.01M | Perf YTD | -45.36% |
| Book/sh | -0.14 | P/C | 615 | EPS past 3/5Y | 9.82% - | ROE | - | 52W High | -49.95% ($9.99) | Perf Year | - |
| Cash/sh | 0.01 | P/FCF | - | Sales past 3/5Y | - | ROIC | - | 52W Low | 25.31% ($3.99) | Perf 3Y | - |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | - | Gross Margin | - | Volatility(W/M) | 4.79% 11.54% | Perf 5Y | - |
| Dividend TTM | - | EV/Sales | - | Sales Y/Y TTM | - | Oper. Margin | - | ATR (14) | 0.58 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 0.06 | EPS Q/Q | - | Profit Margin | - | RSI (14) | 47.25 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 0.06 | Sales Q/Q | - | SMA20 | -0.63% ($5.03) | Beta | - | Target Price | $20.5 |
| Payout | - | Debt/Eq | - | Earnings | 2025/12/03 | SMA50 | -16.34% ($5.98) | Rel Volume | 0.93 | Prev Close | $4.62 |
| Employees | 5 | LT Debt/Eq | - | EPS/Sales Surpr. | 33.33% - | SMA200 | -28.39% ($6.98) | Avg Volume(3M) | 0.01M | Price | $5 |
| IPO | 2025/8/13 | Option/Short | No/Yes | Trades | 35 | Volume | 5,921 | Change | 8.23% |
뉴스 로딩 중...